当前位置: 首页 > 期刊 > 《中国医药科学》 > 2012年第23期
编号:13175227
抽动症治疗新进展(3)
http://www.100md.com 2012年12月1日 《中国医药科学》 2012年第23期
     [7] Debes NM,Skov L,Hjalgrim H.Tourette syndrome, Genetics, neuroanatomy and neurotransmitters[J].Ugeskr Laeger,2008,170(35):2695-2700.

    [8] Spencer TJ,Sallee FR,Gilbert DL,et al.Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome[J].J Atten Disord,2008,11(4):470-481.

    [9] Allen AJ,Kurlan RM,Gilbert DL,et al.Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders[J].Neurology,2005,65 (12):1941-1949.

    [10] Muller N.Anti-inflammatory therapy with a COX-2 inhibitor in Tourette's syndrome[J]. Inflammopharmacology,2004,12(3):271-275.

    [11] Piacentini J,Woods DW,Scahill L,et al.Behavior therapy for children with Tourette disorder: a randomized controlled trial[J].JAMA,2010,303(19):1929-1937.

    [12] Himle MB,Woods DW,Piacentini JC,et al.Brief review of habit reversal training for Tourette syndrome[J]. J Child Neurol,2006,21(8):719-725.

    [13] Garcia-Lopez R,Romero-Gonzalez J,Perea-Milla E,et al.An open study evaluating the efficacy and security of magnesium and vitamin B6 as a treatment of Tourette syndrome in children[J].Med Clin (Barc),2008,131:689–692.

    (收稿日期:2012-06-28), http://www.100md.com(焦富勇等)
上一页1 2 3